Project

Randomized phase III trial of Herceptin™ followed by Taxol plus Herceptin™ versus the combination of Herceptin™ and Taxol as palliative chemotherapy in patients with HER2-overexpressing advanced breast cancer

Automatically Closed · 1999 until 2015

Ruhstaller Thomas, Baumann Michael